Photo: Reuters
Delhi - It had stopped donating and selling shots in April to focus on inoculating its own population as infections exploded
India will resume exports of Covid-19 vaccines from the next quarter, prioritising the global vaccine-sharing platform Covax and neighbouring countries first as supplies rise, the health minister said on Monday.
India, the world’s biggest maker of vaccines, stopped exports of Covid shots in April to focus on inoculating its own population as infections exploded.
The country’s monthly vaccine output has since more than doubled and is set to quadruple to over 300 million doses next month, minister Mansukh Mandaviya said, adding that only excess supplies would be exported.
“We will help other countries and also fulfil our responsibility towards Covax,” he told reporters.
The country had donated or sold 66 million doses to nearly 100 countries before the export halt.
The announcement on resumption of exports comes ahead of Prime Minister Narendra Modi’s visit to Washington this week where vaccines are likely to be discussed at a summit of the leaders of the Quad countries — the United States, India, Japan and Australia.
India wants to vaccinate all its 944 million adults by December and has so far given at least one dose to 64 per cent of them and two doses to 22 per cent.
ALSO READ:
>> Covid-19: India set for huge boost in vaccine supplies, says BJP chief
>> India sets new Covid vaccination record, administers 20m doses in a day
India’s inoculations have jumped since last month, especially as the world’s biggest vaccine maker, the Serum Institute of India, has more than trebled its output of the AstraZeneca shot to 200 million doses a month from April levels.
Indian companies have set up the capacity to produce nearly 3 billion Covid vaccine doses a year.